Parliamentary questions

638. Deputy Ken O'Flynn asked the Minister for Health whether her Department receives routine structured reports from the Health Products Regulatory Authority and the HSE regarding medicines shortages affecting chronic disease management, including respiratory conditions; the frequency and format of such reports; and how this information informs policy and budgetary planning [13764/26]

639. Deputy Ken O'Flynn asked the Minister for Health whether automatic reimbursement mechanisms are in place under community drug schemes to ensure that where a reimbursable medicine is unavailable due to shortage, clinically appropriate substitute medicines are reimbursed without additional administrative burden on patients or prescribers; and if not, whether she will introduce such a mechanism …

640. Deputy Ken O'Flynn asked the Minister for Health whether her Department has undertaken any assessment of the patient safety, treatment interruption or cost implications arising from medicines shortages in the past three years; if so, the findings of that assessment; and if not, whether such an assessment will now be commissioned [13766/26]

641. Deputy Ken O'Flynn asked the Minister for Health whether her Department has issued formal policy guidance to the Health Service Executive or to the National Centre for Pharmacoeconomics regarding the appropriate time horizon to be applied in health technology assessments where medicines are intended to reduce the long-term incidence of chronic diseases such as type 2 diabetes and cardiovascul…

642. Deputy Ken O'Flynn asked the Minister for Health whether her Department requires that lifetime modelling of avoided downstream healthcare costs, including reduced hospital admissions, surgical interventions, dialysis, and long-term disability supports, be incorporated as standard practice in value-for-money assessments conducted under the Health (Pricing and Supply of Medical Goods) Act 2013;…

643. Deputy Ken O'Flynn asked the Minister for Health whether her Department has undertaken any review of the balance between short-term budget impact considerations and long-term prevention-based savings in medicines reimbursement decisions under the Health (Pricing and Supply of Medical Goods) Act 2013; and whether any policy changes are under consideration in this regard. [13787/26]

644. Deputy Ken O'Flynn asked the Minister for Health whether her Department has assessed the extent to which population-level disease prevention benefits are reflected in cost-effectiveness evaluations carried out by or on behalf of the Health Service Executive; and whether she intends to issue policy guidance clarifying how such prevention benefits are to be weighted in future reimbursement deci…

645. Deputy Ken O'Flynn asked the Minister for Health whether any internal Departmental policy documents, circulars, or guidance notes exist concerning the incorporation of long-term prevention outcomes in medicines reimbursement decisions under the Health (Pricing and Supply of Medical Goods) Act 2013; and whether she will arrange for any such documents to be published. [13789/26]

646. Deputy Ken O'Flynn asked the Minister for Health whether her Department receives annual or quarterly statistical reports from the Health Service Executive on discretionary medical card approvals and refusals granted under the General Medical Services scheme in respect of persons aged over 70; and if she will make a statement on the matter. [13798/26]

647. Deputy Ken O'Flynn asked the Minister for Health whether the data provided to her Department by the Health Service Executive on discretionary medical card decisions is disaggregated by age cohort, geographic region, and outcome; and if she will outline the categories of data routinely received. [13799/26]

648. Deputy Ken O'Flynn asked the Minister for Health the number of discretionary medical cards granted to persons aged over 70 following a means assessment in each of the years 2020 to 2025, inclusive; and the number of applications in that age cohort refused following discretionary assessment in each year. [13800/26]

649. Deputy Ken O'Flynn asked the Minister for Health whether her Department has conducted any review, audit, or policy assessment since 2020 of trends in the exercise of discretion in medical card eligibility decisions affecting persons aged over 70; and if she will provide details of any such review. [13801/26]

650. Deputy Ken O'Flynn asked the Minister for Health whether national guidance or policy directives are issued by her Department to ensure consistency in the exercise of discretion under the medical card scheme; and if she will outline the governance arrangements in place to monitor consistency and equity of outcomes for older persons. [13802/26]

651. Deputy Ken O'Flynn asked the Minister for Health whether her Department has assessed the financial impact on older persons who are refused discretionary medical card eligibility but granted a GP Visit Card; and if she will outline any policy considerations arising from such assessment. [13803/26]

652. Deputy David Cullinane asked the Minister for Health when she will consider and publish the review of the physician assistant or associate role in the health service; if she will sanction the grade and role; the steps she is taking to ensure robust governance; the steps she is taking to ensure that other professions which could or do perform some of the roles proposed for physician associates…

653. Deputy Ken O'Flynn asked the Minister for Health the total number of whole-time equivalent GPs practising in the State in each year from 2020 to 2025; the estimated population per GP ratio in each year; and whether demographic change, including inward migration, is factored into primary care workforce planning models. [13869/26]

654. Deputy Ken O'Flynn asked the Minister for Health the total amount of funding allocated in 2025 and to date in 2026 to commission external private providers under Service Level Agreements or Grant Aid Agreements for the provision of primary care level child and adolescent psychological interventions in HSE South West; and the breakdown of that funding by provider and agreement type. [13870/26]

655. Deputy Ken O'Flynn asked the Minister for Health the number of children and adolescents referred to external commissioned providers under Service Level Agreements or Grant Aid Agreements in HSE South West in 2025 and to date in 2026; the average cost per intervention episode; and the average number of sessions delivered per child. [13871/26]

656. Deputy Ken O'Flynn asked the Minister for Health the impact of the commissioning of external psychological service providers in HSE South West on primary care child psychology waiting lists; the reduction achieved in average waiting time in months; and the performance metrics used by the HSE to evaluate value for money and clinical outcomes under these agreements. [13872/26]

657. Deputy Ken O'Flynn asked the Minister for Health whether it is Government policy to continue the commissioning of external private providers for primary care level child and adolescent psychological interventions beyond 2025; and how this commissioning model aligns with national workforce planning for publicly employed psychologists. [13873/26]

658. Deputy Ken O'Flynn asked the Minister for Health whether all Service Level Agreements and Grant Aid Agreements entered into in 2025 in HSE South West for the provision of primary care child psychology services are subject to formal clinical audit; and if so, the dates of audits conducted and whether any compliance or performance issues were identified. [13874/26]

659. Deputy Ken O'Flynn asked the Minister for Health whether her Department receives, holds, or reviews aggregated data from the Health Service Executive or the Primary Care Reimbursement Service on the exercise of discretion in medical card eligibility decisions following a means assessment; the total number of applications in which discretion was considered in each of the years 2020 to 2025; th…

660. Deputy Ken O'Flynn asked the Minister for Health whether any formal reporting framework exists between the Health Service Executive and her Department in respect of discretionary medical card decisions; the frequency of any such reporting; whether performance indicators, audit reviews, or internal compliance checks are conducted in relation to discretionary refusals; and if she will outline t…

661. Deputy Colm Burke asked the Minister for Health the steps that have been taken to progress the lymphoedema and lipoedema model of care further to successful outcomes from Proof-of-Concept services; and if she will make a statement on the matter. [13894/26]

662. Deputy Colm Burke asked the Minister for Health when the draft Public Health (Tobacco Products and Nicotine Inhaling Products) (Amendment) Bill will be published; and if she will make a statement on the matter. [13895/26]